The outlook of companies tied to Sildenafil's history presents a intricate investment picture . While the initial boom generated substantial gains, generic competition have significantly diminished market share . Investing in associated pharmaceutical firms now requires a careful assessment of patent safeguards, evolving medical changes, and the po